Vetfolio - Veterinary Practice Management And Continuing Education Podcasts

The latest installment of VetFolio’s New Product Podcast series features ZYCORTAL® Suspension, from Dechra, a world leader in veterinary endocrinology. ZYCORTAL Suspension contains desoxycorticosterone pivalate (DOCP) which is a mineralocorticoid hormone indicated for use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). ZYCORTAL Suspension was formulated and approved specifically for subcutaneous use. For a great refresher on how to diagnoses and manage Addison’s cases presented by Dr. Audrey Cook, please visit www.Dechra-us.com/CE.